Send us Feedback

BioCryst Pharmaceuticals (BCRX)
Analysis
Data
Financials
 
 
 
 
Balance Sheet    (USD)
Annual | Quarterly
QUARTER ENDING older 30-SEP
2008		 31-DEC
2008		 31-MAR
2009		 30-JUN
2009		 30-SEP
2009		 newer
Cash & Equivalents 16.0M 22.3M 16.3M 13.8M 18.2M
Short Term Investments 48.7M 39.2M 37.9M 28.4M 17.3M
Accounts Receivable 13.1M 12.0M 9.85M 8.07M 11.6M
Inventories 0 0 0 0 0
Pre-paid Expenses 2.33M 1.51M 692K 6.74M 3.20M
Deferred Tax Assets 0 0 376K 376K 374K
Other Current Assets 0 0 0 0 0
Total Current Assets 80.1M 75.0M 65.1M 57.5M 50.7M
Property, Plant & Equipment 5.27M 4.88M 4.57M 4.43M 4.17M
Goodwill & Intangibles 0 0 0 0 0
Other Long-term Assets 14.0M 4.79M 0 0 3.01M
Total Long-Term Assets 19.2M 9.67M 7.47M 7.24M 9.90M
Total Assets 99.4M 84.7M 72.6M 64.7M 60.6M
Accounts Payable 3.24M 5.27M 4.18M 2.79M 3.20M
Accrued Expenses 9.11M 8.44M 0 0 0
Short Term Debt 0 0 0 0 0
Other Current Liabilities 4.38M 2.61M 2.59M 2.58M 2.56M
Total Current Liabilities 17.6M 17.1M 13.6M 13.5M 17.7M
Long Term Debt 0 0 0 0 0
Capital Lease Obligations 0 0 0 0 0
Deferred Income Tax 0 0 0 0 0
Other Long-term Liabilities 46.8M 21.2M 20.5M 19.9M 19.3M
Total Long-term Liabilities 46.8M 21.2M 20.5M 19.9M 19.3M
Minority Interest 0 0 0 0 0
Total Liabilities 64.3M 38.3M 34.1M 33.4M 37.0M
Preferred Stock 0 0 0 0 0
Common Par 382K 383K 383K 383K 387K
Additional Paid-In Capital 294M 295M 297M 298M 301M
Retained Earnings -259M -249M -259M -267M -278M
Treasury Stock 0 0 0 0 0
Other Equity 133K 104K 68K 40K 40K
Total Shareholder's Equity 35.0M 46.4M 38.5M 31.3M 23.5M
 
 
 
 
 
Data Sources:
Market and financial statement data provided by NASDAQ, BATS Exchange, SEC and Xignite Inc. Industry and operating metrics collected from company filings via EDGAR online. For more information on sources and calculations click here.
Wikinvest © 2006, 2007, 2008, 2009. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki